WFDC6, also known as WAP four-disulfide core domain 6, is a protein encoded by the WFDC6 gene in humans. The protein belongs to the Whey Acidic Protein (WAP) family, characterized by a WAP-type 'four-disulfide core' (WFDC) domain. This domain is typified by eight cysteine residues that form four disulfide bonds, contributing to a stable 3-dimensional structure.WFDC6 is typically expressed in epithelial cells, and its expression pattern suggests a role in the protection and regulation of the epithelial environment. Members of the WFDC family often have functions related to innate immunity, including antimicrobial properties and involvement in the modulation of inflammation. They may also participate in processes such as tissue repair and cellular proliferation.
The precise biological functions of WFDC6 are not fully characterized, but its structural features suggest a potential role in defense mechanisms similar to other WFDC proteins. These proteins can act as protease inhibitors, thereby protecting tissues from proteolytic damage during inflammatory responses. Additionally, they may bind to microorganisms directly, contributing to an antimicrobial barrier.WFDC6's function could be significant in the context of mucosal immunity, where it may help maintain the integrity of mucosal surfaces against microbial invasion and contribute to the regulation of immune responses. Alterations in the expression or activity of WFDC6 could be implicated in various pathological conditions, such as infections, chronic inflammatory diseases, and potentially cancer.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can modulate various signaling pathways potentially influencing WFDC6 activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX acts as a non-selective inhibitor of phosphodiesterases, elevating cAMP and cGMP levels in cells, which may indirectly affect WFDC6. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), leading to varied cellular responses that might impact WFDC6 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin, a calcium ionophore, increases intracellular calcium levels, potentially influencing pathways that could affect WFDC6. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187, another calcium ionophore, could indirectly influence WFDC6 activity by altering calcium-dependent signaling pathways. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates pathways like PI3K/Akt, which might have an indirect effect on WFDC6. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, could indirectly affect WFDC6 activity through modulating downstream pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059, a MEK inhibitor in the MAPK/ERK pathway, might influence WFDC6 activity indirectly. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which could lead to changes in cellular processes affecting WFDC6. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a key cell growth and metabolism regulator, possibly influencing WFDC6 activity. | ||||||